The P2Y2 nucleotide receptor requires interaction with alpha v integrins to access and activate G12

J Cell Sci. 2007 May 1;120(Pt 9):1654-62. doi: 10.1242/jcs.03441.

Abstract

The P2Y2 nucleotide receptor (P2Y2R) interacts with alpha v integrins to activate G(o) and induce chemotaxis in human 1321N1 astrocytoma cells. In this study, it was determined that the P2Y2R also requires interaction with alpha v integrins to activate G12 and associated signaling pathways that control chemotaxis in 1321N1 cells. Mutation of the Arg-Gly-Asp (RGD) integrin-binding sequence in the first extracellular loop of the human P2Y2R to Arg-Gly-Glu (RGE), which prevents integrin interaction, did not inhibit G(q) or ERK1/2 signaling by the P2Y2R agonist UTP but completely inhibited activation of G12 and G12-mediated events, including Rho activation, cofilin and myosin light chain-2 phosphorylation, stress fiber formation and chemotaxis towards UTP. The involvement of G12 in all these events was verified by using a dominant negative G alpha12 construct. G12 activation by the P2Y2R also was inhibited by anti-alpha v beta5 integrin antibodies and alpha v integrin antisense oligonucleotides, suggesting that alpha v integrin activity and expression are required for the P2Y2R to activate G12. Co-immunoprecipitation experiments confirmed that G alpha12 protein associates with the wild-type P2Y2R and with alpha v integrins but not with the RGE mutant P2Y2R or with alpha3 integrins. Collectively, these results suggest that alpha v integrin complexes provide the P2Y2R with access to G12, thereby allowing activation of this heterotrimeric G protein that controls actin cytoskeletal rearrangements required for chemotaxis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / pharmacology
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology
  • Cardiac Myosins / metabolism
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cofilin 1 / metabolism
  • Enzyme Inhibitors / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • GTP-Binding Protein alpha Subunits, G12-G13 / genetics
  • GTP-Binding Protein alpha Subunits, G12-G13 / metabolism*
  • GTP-Binding Protein alpha Subunits, Gq-G11 / metabolism
  • Guanosine 5'-O-(3-Thiotriphosphate) / metabolism
  • Humans
  • Integrin alphaV / genetics
  • Integrin alphaV / immunology
  • Integrin alphaV / metabolism*
  • Integrins / immunology
  • Integrins / metabolism
  • Mutation
  • Myosin Light Chains / metabolism
  • Oligonucleotides, Antisense / genetics
  • Pertussis Toxin / pharmacology
  • Phosphorylation / drug effects
  • Protein Binding
  • Pyridines / pharmacology
  • Receptors, Purinergic P2 / genetics
  • Receptors, Purinergic P2 / metabolism*
  • Receptors, Purinergic P2Y2
  • Receptors, Vitronectin / immunology
  • Receptors, Vitronectin / metabolism
  • Signal Transduction / genetics
  • Signal Transduction / physiology*
  • Stress Fibers / metabolism
  • Transfection
  • Uridine Triphosphate / pharmacology
  • rho GTP-Binding Proteins / metabolism

Substances

  • Amides
  • Antibodies, Monoclonal
  • CFL1 protein, human
  • Cofilin 1
  • Enzyme Inhibitors
  • Integrin alphaV
  • Integrins
  • Myosin Light Chains
  • Oligonucleotides, Antisense
  • P2RY2 protein, human
  • Pyridines
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y2
  • Receptors, Vitronectin
  • integrin alphaVbeta5
  • myosin light chain 2
  • Y 27632
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • Pertussis Toxin
  • Extracellular Signal-Regulated MAP Kinases
  • Cardiac Myosins
  • GTP-Binding Protein alpha Subunits, G12-G13
  • GTP-Binding Protein alpha Subunits, Gq-G11
  • rho GTP-Binding Proteins
  • Uridine Triphosphate